Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Shanghai Stock Exchange  >  Shanghai Fosun Pharmaceutical Group Co., Ltd.    600196   CNE000000X38

SHANGHAI FOSUN PHARMACEUTICAL GROUP CO.,

(600196)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
06/01/2020 06/02/2020 06/03/2020 06/04/2020 06/05/2020 Date
31.29 30.88 31.35 31.01 31.2 Last
25093120 26339420 34367720 19713120 19278400 Volume
+1.76% -1.31% +1.52% -1.08% +0.61% Change
Financials
Sales 2020 32 286 M 4 560 M 4 560 M
Net income 2020 3 536 M 499 M 499 M
Net Debt 2020 13 549 M 1 914 M 1 914 M
P/E ratio 2020 22,4x
Yield 2020 1,23%
Sales 2021 38 793 M 5 479 M 5 479 M
Net income 2021 4 348 M 614 M 614 M
Net Debt 2021 15 490 M 2 188 M 2 188 M
P/E ratio 2021 18,3x
Yield 2021 1,54%
Capitalization 75 731 M 10 692 M 10 695 M
EV / Sales 2020 2,77x
EV / Sales 2021 2,35x
Nbr of Employees 31 370
Free-Float 62,3%
More Financials
Company
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical group organized around 5 areas of activities: - research, development and manufacturing of medicines (74.9% of net sales): for the treatment of cardiovascular diseases, digestive tract, metabolism, central nervous system and blood system disorders, and infectious diseases; - sale of medical equipments and diagnosis products (14.7%); - medical and... 
Sector
Pharmaceuticals
Calendar
06/30 | 01:00amShareholder meeting
More about the company
Surperformance© ratings of Shanghai Fosun Pharmaceuti
Trading Rating : Investor Rating :
More Ratings
Latest news on SHANGHAI FOSUN PHARMACEUTI
04/29SHANGHAI FOSUN PHARMACEUTICAL : 1Q Net Fell 19% on Higher Research Expenses
DJ
03/30SHANGHAI FOSUN PHARMACEUTICAL : 2019 Net Profit Rises 23%
DJ
03/20SHANGHAI FOSUN PHARMACEUTICAL GROUP : annual earnings release
03/18SHANGHAI FOSUN PHARMACEUTICAL : Voluntary announcement - the progress of the pla..
PU
03/18SHANGHAI FOSUN PHARMACEUTICAL : Date of board meeting(h shares)
PU
03/17SHANGHAI FOSUN PHARMACEUTICAL : Pfizer, BioNTech to co-develop potential coronav..
RE
03/16BioNTech in China alliance with Fosun over potential coronavirus vaccine
RE
03/15SHANGHAI FOSUN PHARMACEUTICAL : OVERSEAS REGULATORY ANNOUNCEMENT - Announcement ..
PU
03/15SHANGHAI FOSUN PHARMACEUTICAL : OVERSEAS REGULATORY ANNOUNCEMENT - Announcement ..
PU
03/15SHANGHAI FOSUN PHARMACEUTICAL : Fosun Pharma and BioNTech form COVID-19 vaccine ..
PU
03/11SHANGHAI FOSUN PHARMACEUTICAL : Overseas regulatory announcement (h shares)
PU
03/11SHANGHAI FOSUN PHARMACEUTICAL : OVERSEAS REGULATORY ANNOUNCEMENT - Announcement ..
PU
02/24SHANGHAI FOSUN PHARMACEUTICAL : OVERSEAS REGULATORY ANNOUNCEMENT - Announcement ..
PU
02/20SHANGHAI FOSUN PHARMACEUTICAL : banks issue 1.31 billion yuan in cheap loans to ..
RE
01/22SHANGHAI FOSUN PHARMACEUTICAL : Overseas regulatory announcement (h shares)
PU
More news
News in other languages on SHANGHAI FOSUN PHARMACEUTI
04/29SHANGHAI FOSUN PHARMACEUTICAL : 1Q Net Fell 19% on Higher Research Expenses
03/30SHANGHAI FOSUN PHARMACEUTICAL : 2019 Net Profit Rises 23%
03/20SHANGHAI FOSUN PHARMACEUTICAL GROUP : annual earnings release
03/20SHANGHAI FOSUN PHARMACEUTICAL GROUP : Veröffentlichung des Jahresergebnisses
03/20SHANGHAI FOSUN PHARMACEUTICAL GROUP : publication des résultats annuels
More news
Chart SHANGHAI FOSUN PHARMACEUTICAL GROUP CO., LTD.
Duration : Period :
Shanghai Fosun Pharmaceutical Group Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHANGHAI FOSUN PHARMACEUTI
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 32,55 CNY
Last Close Price 31,20 CNY
Spread / Highest target 34,6%
Spread / Average Target 4,33%
Spread / Lowest Target -31,2%
EPS Revisions
Managers
NameTitle
Yi Fang Wu President, CEO & Executive Director
Qi Yu Chen Co-Chairman
Fang Yao Co-Chairman
Qian Ren Chairman-Supervisory Board
Xiao Hui Guan CFO, Chief Accountant Officer & Senior VP